These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25608795)

  • 1. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
    Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
    Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia.
    Shimazu Y; Shimazu Y; Hishizawa M; Hamaguchi M; Nagai Y; Sugino N; Fujii S; Kawahara M; Kadowaki N; Nishikawa H; Sakaguchi S; Takaori-Kondo A
    Cancer Immunol Res; 2016 Feb; 4(2):136-45. PubMed ID: 26681759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of FoxP3+ T regulatory cells in the tumor microenvironment of human colorectal adenomas.
    Hua W; Yuan A; Zheng W; Li C; Cui J; Pang Z; Zhang L; Li Z; Goll R; Cui G
    Pathol Res Pract; 2016 Feb; 212(2):106-12. PubMed ID: 26724144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
    Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
    Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer.
    Hanke T; Melling N; Simon R; Sauter G; Bokemeyer C; Lebok P; Terracciano LM; Izbicki JR; Marx AH
    Int J Clin Exp Pathol; 2015; 8(7):8227-35. PubMed ID: 26339391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.
    Suzuki H; Chikazawa N; Tasaka T; Wada J; Yamasaki A; Kitaura Y; Sozaki M; Tanaka M; Onishi H; Morisaki T; Katano M
    Cancer Immunol Immunother; 2010 May; 59(5):653-61. PubMed ID: 19908042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxP3
    Saleh R; Elkord E
    Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demethylation of the FOXP3 gene in human melanoma cells precludes the use of this epigenetic mark for quantification of Tregs in unseparated melanoma samples.
    Lucas S; van Baren N; de Smet C; Coulie PG
    Int J Cancer; 2012 Apr; 130(8):1960-6. PubMed ID: 21618521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.
    Mahalingam J; Lin CY; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Lin YC
    PLoS One; 2014; 9(9):e108554. PubMed ID: 25268580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small-cell lung cancer-induced immunosuppression by increased human regulatory T cells via Foxp3 promoter demethylation.
    Ke X; Zhang S; Xu J; Liu G; Zhang L; Xie E; Gao L; Li D; Sun R; Wang F; Pan S
    Cancer Immunol Immunother; 2016 May; 65(5):587-99. PubMed ID: 27000869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells.
    Wang Q; Feng M; Yu T; Liu X; Zhang P
    Cell Immunol; 2014 Feb; 287(2):100-5. PubMed ID: 24487033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.
    Niu J; Jiang C; Li C; Liu L; Li K; Jian Z; Gao T
    Cancer Immunol Immunother; 2011 Aug; 60(8):1109-18. PubMed ID: 21547596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.
    Gai XD; Song Y; Li C; Lei YM; Yang B
    Pathol Res Pract; 2013 Dec; 209(12):774-8. PubMed ID: 24080284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FoxP3 demethylation is increased in human colorectal cancer and rat cholangiocarcinoma tissue.
    Schultze FC; Andag R; Alwahsh SM; Toncheva D; Maslyankov S; Yaramov N; von Ahsen N; Brandhorst G; Walson PD; Oellerich M; Petrova DT
    Clin Biochem; 2014 Feb; 47(3):201-5. PubMed ID: 24291052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
    Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndrome.
    Zhu L; Jia L; Liu Z; Zhang Y; Wang J; Yuan Z; Hui R
    Hypertension; 2019 Sep; 74(3):581-589. PubMed ID: 31327269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of different immune checkpoints-expressing CD4
    Al-Mterin MA; Murshed K; Alsalman A; Abu-Dayeh A; Elkord E
    BMC Cancer; 2022 Jun; 22(1):601. PubMed ID: 35655158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell subsets and colorectal cancer: discerning the good from the bad.
    Scurr M; Gallimore A; Godkin A
    Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.